TC Biopharm (Holdings) Plc
TCBP · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $685 | $488 | $372 | $1,052 |
| - Cash | $1 | $1 | $2 | $2 |
| + Debt | $2 | $2 | $1 | $1 |
| Enterprise Value | $686 | $489 | $371 | $1,051 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$3 | -$3 | -$3 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$3 | -$3 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.3 | -1.4 | -3.36 | -3.36 |
| % Growth | 78.6% | 58.3% | 0% | – |
| Operating Cash Flow | -$3 | -$2 | -$2 | -$2 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$3 | -$2 | -$2 | -$2 |